Tretinoin CAS 302-79-4 Supplier – High-Purity Retinoic Acid for Dermatology & Pharma

Why Choose Our Tretinoin?Finetech Industry Limited specializes in supplying high-purity, reliable biochemical and pharmaceutical-grade compounds. Our Tretinoin (all-trans retinoic acid) is rigorously tested to meet the demanding standards of researchers, formulators, and industrial users.✨ Dermatology-Grade Active: Tretinoin is the biologically active form of vitamin A, widely used in dermatology research involving keratinocyte biology, photodamage repair, pigmentation modulation, and epidermal turnover.🔬 Guaranteed Purity: Each batch is verified at ≥ 98% purity (Finetech [...]

Exploring the Significance of Allantoic Acid and Its Role in Biological Metabolic Pathway

Exploring the Significance of Allantoic Acid and Its Role in Biological Metabolic Pathway Allantoic acid, 99-16-1 also known as 2,2-bis(aminocarbonylamino)ethanoic acid, is a crystalline acid with the chemical formula C4H8N4O4. It is a significant organic compound found in nature and has various applications and properties.In nature, allantoic acid is produced from allantoin by the process of hydrolysis. It is a key intermediate in the metabolic pathway of purine degradation in organisms. Allantoate, an intermediate in the allantoin degradation to glyoxylate pathway, is the end [...]

Idarubicin: Mechanism of Action, Side Effects, and Clinical Applications in Cancer Treatment

Idarubicin 57852-57-0is a potent chemotherapy drug belonging to the anthracycline class, primarily used in the treatment of various types of cancer, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). Its mechanism of action, side effects, and clinical applications make it a crucial component of cancer treatment regimens.Mechanism of Action:Idarubicin exerts its anticancer effects by interfering with the DNA and RNA synthesis of cancer cells. It does so by intercalating between DNA base pairs, inhibiting the activity of topoisomerase II enzyme, and generating free radi [...]